PRECISION BIOSCIENCES INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
PRECISION BIOSCIENCES INC (DTIL) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$97.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-03-26
- PRECISION BIOSCIENCES INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was -$97.00K.
- PRECISION BIOSCIENCES INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was -$81.00K.
- PRECISION BIOSCIENCES INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was -$33.00K.
- PRECISION BIOSCIENCES INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was -$121.00K, a 112.56% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$97.00K 10-K · filed 2025-03-26 | |
| 2023-12-31 | -$81.00K 10-K · filed 2025-03-26 | -$85.00K 10-K · filed 2024-03-27 |
| 2022-12-31 | -$33.00K 10-K · filed 2024-03-27 | |
| 2021-12-31 | -$121.00K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $963.00K 10-K · filed 2022-03-15 | |
| 2019-12-31 | -$1.78M 10-K · filed 2021-03-18 | $1.78M 10-K · filed 2020-03-10 |
| 2018-12-31 | $270.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |